A citation-based method for searching scientific literature

Lars J Grimm, Victoria L Mango, Jennifer A Harvey, Donna M Plecha, Emily F Conant. AJR Am J Roentgenol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis.
María Nieves Plana, Carmen Carreira, Alfonso Muriel, Miguel Chiva, Víctor Abraira, Jose Ignacio Emparanza, Xavier Bonfill, Javier Zamora. Eur Radiol 2012
112
100

Diagnostic Accuracy of Digital Mammography in the Detection of Breast Cancer.
Muhammad Zeeshan, Basit Salam, Qazi Saad B Khalid, Shahbaz Alam, Raza Sayani. Cureus 2018
14
100

Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.
Lusine Yaghjyan, Graham A Colditz, Laura C Collins, Stuart J Schnitt, Bernard Rosner, Celine Vachon, Rulla M Tamimi. J Natl Cancer Inst 2011
148
100



Screening for breast cancer.
Joann G Elmore, Katrina Armstrong, Constance D Lehman, Suzanne W Fletcher. JAMA 2005
471
100

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
100

A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
Amanda Kupstas, Warda Ibrar, R David Hayward, David Ockner, Cheryl Wesen, Jeffrey Falk. Am J Surg 2018
11
100

Breast-Specific γ-Imaging for the Detection of Mammographically Occult Breast Cancer in Women at Increased Risk.
Rachel F Brem, Rachel C Ruda, Jialu L Yang, Caitrín M Coffey, Jocelyn A Rapelyea. J Nucl Med 2016
21
100

Fast MRI breast cancer screening - Ready for prime time.
Sasan Partovi, David Sin, Ziang Lu, Leah Sieck, Holly Marshall, Ramya Pham, Donna Plecha. Clin Imaging 2020
14
100

Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Christopher E Comstock, Constantine Gatsonis, Gillian M Newstead, Bradley S Snyder, Ilana F Gareen, Jennifer T Bergin, Habib Rahbar, Janice S Sung, Christina Jacobs, Jennifer A Harvey,[...]. JAMA 2020
85
100

Breast MRI for Evaluation of Response to Neoadjuvant Therapy.
Beatriu Reig, Alana A Lewin, Linda Du, Laura Heacock, Hildegard K Toth, Samantha L Heller, Yiming Gao, Linda Moy. Radiographics 2021
3
100

Breast MR imaging screening in women with a history of breast conservation therapy.
Hye Mi Gweon, Nariya Cho, Wonshik Han, Ann Yi, Hyeong-Gon Moon, Dong-Young Noh, Woo Kyung Moon. Radiology 2014
51
100

Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
Dorothy A Sippo, Geoffrey M Rutledge, Kristine S Burk, Sarah F Mercaldo, Brian N Dontchos, Christine E Edmonds, Constance D Lehman. AJR Am J Roentgenol 2019
9
100

Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Elisa Rush Port, Anna Park, Patrick I Borgen, Elizabeth Morris, Leslie L Montgomery. Ann Surg Oncol 2007
80
100

Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI.
David V Schacht, Ken Yamaguchi, Jessica Lai, Kirti Kulkarni, Charlene A Sennett, Hiroyuki Abe. AJR Am J Roentgenol 2014
55
100

Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
A P Benveniste, T Ortiz-Perez, L O Ebuoma, K A Sepulveda, F J Severs, A Roark, T Wang, E L Sedgwick. Eur J Radiol 2017
5
100

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
Sara A Hurvitz, Miguel Martin, W Fraser Symmans, Kyung Hae Jung, Chiun-Sheng Huang, Alastair M Thompson, Nadia Harbeck, Vicente Valero, Daniil Stroyakovskiy, Hans Wildiers,[...]. Lancet Oncol 2018
192
100


Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors.
Chana Weinstock, Cristina Campassi, Olga Goloubeva, Kathleen Wooten, Susan Kesmodel, Emily Bellevance, Steven Feigenberg, Olga Ioffe, Katherine H R Tkaczuk. Springerplus 2015
31
100

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
100

FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sara Sheikhbahaei, Tyler J Trahan, Jennifer Xiao, Mehdi Taghipour, Esther Mena, Roisin M Connolly, Rathan M Subramaniam. Oncologist 2016
58
100

Variability in reexcision following breast conservation surgery.
Laurence E McCahill, Richard M Single, Erin J Aiello Bowles, Heather S Feigelson, Ted A James, Tom Barney, Jessica M Engel, Adedayo A Onitilo. JAMA 2012
334
100

Prevalence of mammographically dense breasts in the United States.
Brian L Sprague, Ronald E Gangnon, Veronica Burt, Amy Trentham-Dietz, John M Hampton, Robert D Wellman, Karla Kerlikowske, Diana L Miglioretti. J Natl Cancer Inst 2014
205
100

Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer.
Nehmat Houssami, Robin M Turner, Monica Morrow. Breast Cancer Res Treat 2017
79
100

Abbreviated Breast Magnetic Resonance Imaging for Supplemental Screening of Women With Dense Breasts and Average Risk.
Susan P Weinstein, Katrina Korhonen, Claire Cirelli, Mitchell D Schnall, Elizabeth S McDonald, Austin R Pantel, Samantha Zuckerman, Ari Borthakur, Emily F Conant. J Clin Oncol 2020
16
100



Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
100

Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study.
Rachel F Brem, László Tabár, Stephen W Duffy, Marc F Inciardi, Jessica A Guingrich, Beverly E Hashimoto, Marla R Lander, Robert L Lapidus, Mary Kay Peterson, Jocelyn A Rapelyea,[...]. Radiology 2015
169
100


Background parenchymal enhancement on breast MRI: impact on diagnostic performance.
Wendy B DeMartini, Franklin Liu, Sue Peacock, Peter R Eby, Robert L Gutierrez, Constance D Lehman. AJR Am J Roentgenol 2012
116
100

Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.
Jeon-Hor Chen, Shadfar Bahri, Rita S Mehta, Philip M Carpenter, Christine E McLaren, Wen-Pin Chen, Peter T Fwu, David J B Hsiang, Karen T Lane, John A Butler,[...]. J Surg Oncol 2014
28
100

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, Kevin Strobel, Hans H Schild, Ralf-Dieter Hilgers, Heribert B Bieling. J Clin Oncol 2014
311
100

Diagnostic performance of digital versus film mammography for breast-cancer screening.
Etta D Pisano, Constantine Gatsonis, Edward Hendrick, Martin Yaffe, Janet K Baum, Suddhasatta Acharyya, Emily F Conant, Laurie L Fajardo, Lawrence Bassett, Carl D'Orsi,[...]. N Engl J Med 2005
100

Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging.
Valencia King, Jennifer Kaplan, Malcolm C Pike, Laura Liberman, D David Dershaw, Carol H Lee, Jennifer D Brooks, Elizabeth A Morris. Breast J 2012
67
100

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
100

Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.
Marije F Bakker, Stéphanie V de Lange, Ruud M Pijnappel, Ritse M Mann, Petra H M Peeters, Evelyn M Monninkhof, Marleen J Emaus, Claudette E Loo, Robertus H C Bisschops, Marc B I Lobbes,[...]. N Engl J Med 2019
185
100

Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Glen Lo, Anabel M Scaranelo, Hana Aboras, Sandeep Ghai, Supriya Kulkarni, Rachel Fleming, Karina Bukhanov, Pavel Crystal. Radiology 2017
34
100

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.
Gunter von Minckwitz, Michael Untch, Jens-Uwe Blohmer, Serban D Costa, Holger Eidtmann, Peter A Fasching, Bernd Gerber, Wolfgang Eiermann, Jörn Hilfrich, Jens Huober,[...]. J Clin Oncol 2012
100

Screening breast ultrasound: past, present, and future.
Rachel F Brem, Megan J Lenihan, Jennifer Lieberman, Jessica Torrente. AJR Am J Roentgenol 2015
98
100

Atypical hyperplasia of the breast--risk assessment and management options.
Lynn C Hartmann, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh. N Engl J Med 2015
165
100

Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
Nathalie Johnson, Leslie Sorenson, Laura Bennetts, Karen Winter, Sally Bryn, William Johnson, Margie Glissmeyer, Jennifer Garreau, Deb Blanchard. Am J Surg 2014
15
100



Screening MRI in Women With a Personal History of Breast Cancer.
Constance D Lehman, Janie M Lee, Wendy B DeMartini, Daniel S Hippe, Mara H Rendi, Grace Kalish, Peggy Porter, Julie Gralow, Savannah C Partridge. J Natl Cancer Inst 2016
82
100

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
Debra L Monticciolo, Mary S Newell, R Edward Hendrick, Mark A Helvie, Linda Moy, Barbara Monsees, Daniel B Kopans, Peter R Eby, Edward A Sickles. J Am Coll Radiol 2017
111
100

Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
Tina J Hieken, Judy C Boughey, Katie N Jones, Sejal S Shah, Katrina N Glazebrook. Ann Surg Oncol 2013
78
100

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
100

Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004-2010.
Lee G Wilke, Tomasz Czechura, Chih Wang, Brittany Lapin, Erik Liederbach, David P Winchester, Katharine Yao. JAMA Surg 2014
129
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.